Suven Life Sciences Ltd
NSE:SUVEN

Watchlist Manager
Suven Life Sciences Ltd Logo
Suven Life Sciences Ltd
NSE:SUVEN
Watchlist
Price: 125 INR 0.68%
Market Cap: 27.3B INR
Have any thoughts about
Suven Life Sciences Ltd?
Write Note

Suven Life Sciences Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Suven Life Sciences Ltd
Total Equity Peer Comparison

Comparables:
DIVISLAB
DCAL
WINDLAS
SYNGENE
I
INNOVACAP

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Suven Life Sciences Ltd
NSE:SUVEN
Total Equity
â‚ą2.7B
CAGR 3-Years
36%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Divi's Laboratories Ltd
NSE:DIVISLAB
Total Equity
â‚ą135.7B
CAGR 3-Years
13%
CAGR 5-Years
50%
CAGR 10-Years
N/A
Dishman Carbogen Amcis Ltd
NSE:DCAL
Total Equity
â‚ą56.3B
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Windlas Biotech Ltd
NSE:WINDLAS
Total Equity
â‚ą4.5B
CAGR 3-Years
31%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Syngene International Ltd
NSE:SYNGENE
Total Equity
â‚ą42.6B
CAGR 3-Years
15%
CAGR 5-Years
17%
CAGR 10-Years
N/A
I
Innova Captab Ltd
NSE:INNOVACAP
Total Equity
â‚ą8.3B
CAGR 3-Years
79%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Suven Life Sciences Ltd's Total Equity?
Total Equity
2.7B INR

Based on the financial report for Jun 30, 2024, Suven Life Sciences Ltd's Total Equity amounts to 2.7B INR.

What is Suven Life Sciences Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
-15%

Over the last year, the Total Equity growth was -28%. The average annual Total Equity growth rates for Suven Life Sciences Ltd have been 36% over the past three years , -15% over the past five years .

Back to Top